Alejandro Speck-Planche (A Speck-Planche)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 13

Top Venues

Molecular diversity

Expert opinion on drug discovery

Future medicinal chemistry

Biomedicines

Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University

University of Porto (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University

Russia

Associate Professor :: Department of Chemistry

Education History

University of Porto Jan 1o 2012 - Dec 21o 2015

Portugal

PHD :: LAQV@REQUIMTE/Department of Chemistry and Biochemistry

Publications

Valeria V Kleandrova, Maria Natália Dias Soeiro Cordeiro, Alejandro Speck-Planche
Current in silico methods for multi-target drug discovery in early anticancer research: the rise of the perturbation-theory machine learning approach. Future medicinal chemistry (2023)
Valeria V Kleandrova, Maria Natália Dias Soeiro Cordeiro, Alejandro Speck-Planche
Optimizing drug discovery using multitasking models for quantitative structure-biological effect relationships: an update of the literature. Expert opinion on drug discovery (2023)
Alejandro Speck-Planche, Valeria V Kleandrova
Multi-Condition QSAR Model for the Virtual Design of Chemicals with Dual Pan-Antiviral and Anti-Cytokine Storm Profiles. ACS omega 7 (36) (2022)
Valeria V Kleandrova, Alejandro Speck-Planche
PTML Modeling for Pancreatic Cancer Research: In Silico Design of Simultaneous Multi-Protein and Multi-Cell Inhibitors. Biomedicines 10 (2) (2022)
Alejandro Speck-Planche, Valeria V Kleandrova
The latest guidance on the simultaneous design of virtually active and non-hemolytic peptides. Expert opinion on drug discovery 17 (10) (2022)
Alejandro Speck-Planche, Valeria V Kleandrova, Marcus Tullius Scotti
In Silico Drug Repurposing for Anti-Inflammatory Therapy: Virtual Search for Dual Inhibitors of Caspase-1 and TNF-Alpha. Biomolecules 11 (12) (2021)
Valeria V Kleandrova, Marcus Tullius Scotti, Alejandro Speck-Planche
Computational Drug Repurposing for Antituberculosis Therapy: Discovery of Multi-Strain Inhibitors. Antibiotics (Basel, Switzerland) 10 (8) (2021)
Valeria V Kleandrova, Julio A Rojas-Vargas, Marcus Tullius Scotti, Alejandro Speck-Planche
PTML modeling for peptide discovery: in silico design of non-hemolytic peptides with antihypertensive activity. Molecular diversity (2021)
Valeria V Kleandrova, Alejandro Speck-Planche
The urgent need for pan-antiviral agents: from multitarget discovery to multiscale design. Future medicinal chemistry 13 (1) (2020)
Valeria V Kleandrova, Marcus Tullius Scotti, Luciana Scotti, Anuraj Nayarisseri, Alejandro Speck-Planche
Cell-based multi-target QSAR model for design of virtual versatile inhibitors of liver cancer cell lines. SAR and QSAR in environmental research 31 (11) (2020)
Alejandro Speck-Planche, Marcus T Scotti
BET bromodomain inhibitors: fragment-based in silico design using multi-target QSAR models. Molecular diversity 23 (3) (2018)
Alejandro Speck-Planche, M Natália D S Cordeiro
Fragment-based in silico modeling of multi-target inhibitors against breast cancer-related proteins. Molecular diversity 21 (3) (2017)
Alejandro Speck-Planche, M Natália Dias Soeiro Cordeiro
Speeding up Early Drug Discovery in Antiviral Research: A Fragment-Based in Silico Approach for the Design of Virtual Anti-Hepatitis C Leads. ACS combinatorial science 19 (8) (2017)

Alejandro Speck-Planche.css-eqlu8i{font-size:small;padding-left:4px;} (A Speck-Planche)

Publication Activity (10 Years)

Top Topics

Top Venues

Alejandro Speck-Planche (A Speck-Planche)